Price Alert

ShockWave Medical Inc. (SWAV)

NASDAQ: SWAV · Real-Time Price · USD

334.75

-0.08 (-0.02%)

At close: May 30, 2024, 10:00 PM

ShockWave Medical Statistics

Share Statistics

ShockWave Medical has 37.54M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	37.54M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	37.48M
Failed to Deliver (FTD) Shares	163
FTD / Avg. Volume	0.01%

Short Selling Information

The latest short interest is 2.3M, so 0% of the outstanding shares have been sold short.

Short Interest	2.3M
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.72

Valuation Ratios

The PE ratio is 47.49 and the forward PE ratio is 46.49. ShockWave Medical's PEG ratio is -1.42.

PE Ratio	47.49
Forward PE	46.49
PS Ratio	9.58
Forward PS	9.4
PB Ratio	10.46
P/FCF Ratio	42.27
PEG Ratio	-1.42

Financial Ratio History

Enterprise Valuation

ShockWave Medical has an Enterprise Value (EV) of 7.44B.

EV / Sales	10.18
EV / EBITDA	42.17
EV / EBIT	37.93
EV / FCF	44.95

Financial Position

The company has a current ratio of 11.76, with a Debt / Equity ratio of 1.15.

Current Ratio	11.76
Quick Ratio	10.73
Debt / Equity	1.15
Debt / EBITDA	4.37
Debt / FCF	4.66
Interest Coverage	26.79

Financial Efficiency

Return on Equity is 22.03% and Return on Invested Capital is 9.57%.

Return on Equity	22.03%
Return on Assets	9.4%
Return on Invested Capital	9.57%
Revenue Per Employee	$497.43K
Profits Per Employee	$100.33K
Employee Count	1,468
Asset Turnover	0.47
Inventory Turnover	0.89

Taxes

Income Tax	27M
Effective Tax Rate	15.49%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 0.88, so ShockWave Medical's price volatility has been higher than the market average.

Beta	0.88
52-Week Price Change	n/a
50-Day Moving Average	325.08
200-Day Moving Average	240.56
Relative Strength Index (RSI)	77.62
Average Volume (20 Days)	1,246,461

Income Statement

In the last 12 months, ShockWave Medical had revenue of 730.23M and earned 147.28M in profits. Earnings per share was 4.01.

Revenue	730.23M
Gross Profit	634.84M
Operating Income	165.99M
Net Income	147.28M
EBITDA	176.35M
EBIT	180.48M
Earnings Per Share (EPS)	4.01

Full Income Statement

Balance Sheet

The company has 328.42M in cash and 770.61M in debt, giving a net cash position of -442.19M.

Cash & Cash Equivalents	328.42M
Total Debt	770.61M
Net Cash	-442.19M
Retained Earnings	110.47M
Total Assets	1.64B
Working Capital	1.18B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 196.05M and capital expenditures -30.59M, giving a free cash flow of 165.46M.

Operating Cash Flow	196.05M
Capital Expenditures	-30.59M
Free Cash Flow	165.46M
FCF Per Share	4.51

Full Cash Flow Statement

Margins

Gross margin is 86.94%, with operating and profit margins of 22.73% and 20.17%.

Gross Margin	86.94%
Operating Margin	22.73%
Pretax Margin	23.87%
Profit Margin	20.17%
EBITDA Margin	24.15%
EBIT Margin	22.73%
FCF Margin	22.66%

Dividends & Yields

SWAV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	2.11%
FCF Yield	2.37%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for SWAV.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	40.55
Graham Upside	-87.89%

Scores

Altman Z-Score	10.29
Piotroski F-Score	6